Background-Experimental studies have demonstrated the role of vitamin D in key pathways related to cardiovascular health. While several studies have investigated the impact of vitamin D therapy on outcomes in subjects with prevalent heart failure, limited research exists on the relationship of dietary vitamin D consumption with the risk of heart failure. Thus, we sought to investigate whether dietary vitamin D consumption was associated with a lower risk of incident heart failure in a large prospective cohort of male physicians.
new cases are diagnosed each year (2) . Because mortality rates remain > 50% within 5 years of HF diagnosis (3), effective therapies for HF prevention are sorely needed.
Vitamin D is a fat-soluble vitamin that plays a critical role in mineral homeostasis and skeletal health. Recently, vitamin D has been implicated in the pathogenesis of non-skeletal chronic diseases, including cardiovascular disease (4) (5) (6) (7) (8) (9) (10) . Experimental studies in both animals and human tissue have supported the importance of vitamin D in cardiovascular health through its effect on inflammation (11) , the renin-angiotensin system (12) and cardiomyocyte structure and function (10) .. Prospective studies have demonstrated an inverse association between baseline serum 25-hydroxyvitamin D (25-OH vitamin D) levels and the development of hypertension (5) , diabetes mellitus (6) , and coronary heart disease (7) . Other investigators have reported cross-sectional associations between lower vitamin D levels and both prevalent HF as well as poor HF outcomes (8, 9) .
Despite these clinical observations, results from both prospective and randomized, controlled trials (RCT) of vitamin D supplementation on cardiovascular outcomes have been inconclusive (9, (13) (14) (15) . Several studies have investigated the impact of vitamin D therapy on outcomes in subjects with prevalent HF (13, 14) , however limited research exists on the relationship of vitamin D supplementation and the risk of HF (15) (16) (17) . These studies have been conducted in either exclusively female (15, 16) or elderly (17) populations, and examined vitamin D consumption from supplement use and not from diet. Thus, we sought to investigate whether dietary vitamin D consumption was associated with a lower risk of incident HF in a large prospective cohort of male physicians.
Methods

Study Population
The Physicians' Health Study (PHS) I was a randomized, double-blind, placebo-controlled 2 × 2 factorial trial of low-dose aspirin and beta carotene on the primary prevention of cardiovascular disease and cancer in 22,071 male physicians. The PHS II was a randomized, double-blind, placebo controlled 2 × 2 × 2 × 2 factorial trial of vitamins E, C, multivitamins, and beta-carotene on the risk of cardiovascular disease and cancer. PHS II included 7,641 subjects from PHS I and an additional 7,000 newly recruited male physicians (1997) (1998) (1999) (2000) (2001) . Detailed descriptions of the PHS I and II have been published previously (18, 19) . Participants of PHS I and II who completed a food frequency questionnaire (FFQ) between 1997 and 2001 were eligible for inclusion in the study (n = 21,075). Each participant provided written informed consent, and the study protocol was approved by the institutional review board at Brigham and Women's Hospital, Boston, Massachusetts.
For this project, we excluded participants because of (1) prevalent HF (n = 470), and (2) missing information on dietary vitamin D consumption (n = 970). Our final sample was 19,635 subjects.
Vitamin D consumption
Information on dietary vitamin D consumption was obtained from a baseline food frequency questionnaire (FFQ) collected between 1997 and 2001. The validity and reproducibility of FFQs have been published elsewhere (20) . Nutrients were computed by using the foodcomposition database from the Harvard School of Public Health and manufacturer information, and this technique has been described previously (21) . We used the residual method to adjust nutrients for energy intake, including dietary vitamin D (22) .
Ascertainment of Incident HF
A questionnaire was mailed to participants every 6 months during the first year and annually thereafter in order to obtain information on compliance with the intervention and the occurrence of new medical diagnoses including HF. We have previously described the validation of HF in a subsample in this cohort (23) .
Other variables
Demographic information was obtained through self-reported questionnaires. At baseline, each subject provided information on exercise; ("How often do you exercise vigorously enough to work up sweat?"), and exercise per week was categorized into 0, <1, 1-2, 3-4, or 5-7 d/wk; smoking history (never, former, or current smoker); and alcohol intake (daily, weekly, monthly, and rarely/almost never). Information about comorbidities -including hypertension, valvular heart disease, atrial fibrillation, coronary heart disease, and diabetes mellitus -was collected at baseline and through follow-up questionnaires. Dietary information was collected through FFQ.
Statistical analyses
We created quintiles of age-and calorie-adjusted dietary vitamin D. We used Cox proportional hazards regression to estimate the hazard ratio of HF using the lowest quintile as the reference. The multivariable models adjusted for age, body mass index (BMI), race, energy intake, alcohol consumption, exercise, smoking, and atrial fibrillation. We considered hypertension, diabetes mellitus, and coronary heart disease to be intermediate factors in the vitamin D-HF relation and did not include them in the multivariable model.
We tested the proportional hazards assumption including an interaction between logarithmictransformed person-time and vitamin D level in the model. We further explored the possibility of a non-linear relationship using a partial likelihood ratio test by comparing a model with log-transformed vitamin D with a model that included a squared and cubic term of vitamin D. All analyses were performed using SAS (version 9.3; SAS Institute), and the alpha level was set at 0.05. All P values were 2-sided. Higher intake of dietary vitamin D was not associated with incident HF in both minimallyand fully-adjusted models ( Table 2) . We did observe a small elevated risk for HF within quintile 2 in both models. Hazard ratios (95% CI) of incident HF were 1.0 (reference), 
Results
Discussion
In this prospective study of US male physicians, we found that higher intake of dietary vitamin D was not associated with the risk of HF. The observed small, yet elevated risk of HF in the second quintile of dietary vitamin D, HR 1.29 (95% CI: 1.04 to 1.60) may be due to chance given the lack of association across the remaining quintiles.
Limited data exist on the relation of vitamin D with incident HF. To our knowledge, only two randomized trials examined the effects of vitamin D supplementation on HF risk. Specifically, Hsia et al. showed that 400 IU of vitamin D3 supplementation (with concomitant calcium supplementation) did not decrease the risk for HF hospitalization compared to placebo in the Women's Health Initiative sample of over 36,000 postmenopausal women after an average of 7 years of follow-up, HR 0.95 (95% CI: 0.83 to 1.10) (15) . In a secondary analysis of the Women's Health Initiative that was restricted to subjects without prevalent HF, Donneyong et al. found that vitamin D and calcium supplementation reduced the risk for incident HF by 37% (HR 0.63, 95% CI: 0.46 to 0.87) in post-menopausal women with a "low-risk" profile (defined by the absence of hypertension, diabetes mellitus, CHD, or CVD) compared to those with a "high-risk" profile. Overall, supplementation with calcium plus vitamin D was not associated with risk of HF in this cohort, HR 0.95 (95% CI: 0.82 to 1.09) (16 (27) . Absence of an association between vitamin D and HF is consistent with our recent report showing no association between vitamin D binding protein (a major transporter of vitamin D) and HF risk (28) .
Vitamin D status has been suggested as a possible surrogate marker for overall poor metabolic health or socio-demographic status, potentially confounding its relationship with cardiovascular disease outcomes (29) . Our null findings come from a cohort comprised entirely of US male physicians with largely uniform socio-demographic status. Similarly, a recent gene association study did not find a relationship between the variation in vitamin D metabolism and risk of cardiovascular disease, raising the possibility that there may not be a causal relationship between vitamin D levels and cardiovascular disease (10, 30) .
The present study has some limitations. As an observational study, it is possible that residual confounding by unmeasured factors such as sunlight exposure may partially explain our findings. Subjects may have consumed additional vitamin D from multivitamin use, however the addition of multivitamin use to the fully-adjusted model did not change our results. We analyzed a single assessment of dietary vitamin D consumption and this may not adequately reflect the long-term dietary intake of vitamin D in these patients. We lacked baseline information on serum vitamin D levels, which could influence results towards or away from the null hypothesis. Additionally, we lacked information on subjects' kidney and liver function, both of which can influence the level of bioactive vitamin D. Study participants were male physicians and it is unknown if the results are generalizable to women, other ethnic groups, and/or the general population.
The large sample size, detailed FFQ, long duration of follow-up, and high positive predictive value of self-reported HF by members of the cohort are strengths of this study.
In conclusion, higher intake of dietary vitamin D was not associated with incident HF in this population of professionally-employed middle-aged males.
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